![](/img/cover-not-exists.png)
1238PTRY - A PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF COMBINED TRASTUZUMAB AND THE HSP90 INHIBITOR AUY922 IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH HER2 OVEREXPRESSION OR AMPLIFICATION OR MUTATION
Nogova, L., Mattonet, C., Scheffler, M., Michels, S., Bos, M., Heukamp, L.C., Schildhaus, H., Fuhr, U., Eberhardt, W.E., Reis, H., Wiesweg, M., Schmid, K.W., Schoch, G., Serke, M., Ko, Y., Schuler, M.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu349.17
Date:
September, 2014
File:
PDF, 33 KB
english, 2014